This test is most useful if any of these apply to you.
A bone density scan tells you how thin your bones are. It can't tell you why. Often something else in your body is doing the damage: an overactive gland, slowing kidneys, a vitamin shortage, or a problem in the bone marrow.
In a 2025 series of 890 people referred for low bone density or fractures, 67% had at least one abnormal lab result pointing to a possible cause. This panel is a blood-based first pass at finding those causes, and it all comes from one draw.
Bone isn't inert. Your body dissolves old bone and lays down new bone all the time, and that cycle runs on calcium, phosphorus, vitamin D, and a few hormones that tell your skeleton when to give up minerals and when to keep them. When one of those inputs goes wrong, your bones often pay the price. The panel checks the systems most likely to cause that.
Doctors call this secondary osteoporosis. The higher estimates put it at up to about one third of osteoporosis in postmenopausal women, more than half of cases in premenopausal women, and roughly half to four fifths of cases in men. Other reviews come in lower, closer to one in five for postmenopausal women, so the exact share is still debated. It matters because a bone drug may not work well if the underlying cause goes unfound and untreated.
Four small glands in your neck make parathyroid hormone, or PTH. Its job is to keep blood calcium steady. When calcium runs low, it can pull mineral out of bone to make up the gap.
That's why these markers only make sense read together. Your calcium can look normal precisely because PTH is working overtime to hold it there, at your skeleton's expense. Vitamin D sets how much calcium you absorb from food. Alkaline phosphatase, or ALP, is a protein made by bone-building cells, so it rises when bone turnover speeds up or when new bone isn't hardening the way it should.
In the 890-person series, the two most common findings were abnormal vitamin D and abnormal PTH. Most low vitamin D results were mildly low. Some labs flag that range and others call it adequate, so look at your actual number, not just whether it's highlighted.
Your kidneys activate vitamin D and decide how much calcium and phosphorus to keep. When they slow down, the whole calcium system drifts and PTH climbs. The panel measures creatinine, a waste product from muscle, and uses it to estimate your kidney filtering rate, or eGFR. Kidney function also decides which drugs are safe for you, because severe kidney impairment can rule out several common osteoporosis drugs.
Too much thyroid hormone speeds up bone breakdown. Thyroid-stimulating hormone, or TSH, is the brain's signal to the thyroid, so a low TSH usually means the thyroid is running hot. In large studies, fracture risk climbed most when TSH was very low. The fracture link is strongest when the gland itself is overactive. A thyroid pill dose that's too strong has weaker fracture data behind it, but it's one of the easier causes to fix.
The marrow that makes your blood cells lives inside your bones. The blood count is the panel's window into it. Anemia can point to poor absorption, including celiac disease. Celiac disease is a gut reaction to gluten that can block calcium and vitamin D absorption.
Abnormal counts across several cell types can be an early sign of a marrow disorder. Myeloma is one example. It can weaken bone from inside the marrow. Even results inside the normal range can carry information: in older men without anemia, a wider spread of red cell sizes was linked to higher hip fracture risk.
The common shortcut is to check vitamin D alone. That catches the single most frequent finding and misses most of the rest: overactive parathyroids, kidney decline, thyroid excess, and marrow problems. Each calls for a different fix.
| Pattern | What it suggests | Next step |
|---|---|---|
| High calcium, with PTH high or high-normal | Primary hyperparathyroidism: a parathyroid gland is making too much hormone on its own. This is one of the most correctable causes of bone loss. | Repeat calcium and PTH from the same draw, then get endocrine review. Surgery to remove the overactive gland is often the fix. |
| Normal or low calcium, high PTH, low vitamin D | Secondary hyperparathyroidism: your glands are making up for a vitamin D shortage by pulling calcium from bone. | Bring vitamin D up, then retest PTH. If PTH stays high once vitamin D is normal, look further. |
| High PTH, low eGFR, high phosphorus | Bone and mineral disease driven by the kidneys. | Get kidney review. This also changes which bone drugs are safe. |
| High ALP with low phosphorus or low vitamin D | Possible osteomalacia. In osteomalacia, new bone does not harden properly, so it can mimic osteoporosis on a scan. | Correct vitamin D and recheck before starting an osteoporosis drug. |
A low TSH with otherwise normal minerals points toward the thyroid. If you take thyroid medication, the first thing to check is the dose. A high ALP on its own, with normal calcium, phosphorus, and vitamin D, can come from the liver or from a localized bone condition called Paget disease, and is worth a follow-up. An unusually low ALP deserves attention too. It can point to hypophosphatasia, a rare inherited disorder of bone mineralization that should be ruled out before osteoporosis treatment.
In the blood count, the warning sign is two or more cell types that are low at the same time and can't be explained. That earns a hematology review. A single mild anemia with small red cells points first to iron loss or poor absorption.
Start with whatever changes treatment. High calcium, a kidney filtering rate in the mid-30s or lower, or several abnormal blood counts each need review before you start any bone drug. That kidney range is where bisphosphonate pills are usually avoided, and the infusion form is ruled out below 35. Low vitamin D is common and usually fixable, but correct it and then retest PTH, because a gland problem can hide behind a vitamin shortage.
Some companion tests add the most. A 24-hour urine calcium shows whether your kidneys are leaking calcium or your gut isn't absorbing it. In 173 otherwise healthy women with osteoporosis, 32% had a previously undiagnosed disorder. Urine calcium, blood calcium, and PTH together, plus TSH in women on thyroid pills, would have caught 85% of them. Men should add testosterone. Anyone with anemia or digestive symptoms should add a celiac antibody test.
How much this finds depends on who you are. In one primary care study of older women, most abnormal results led to no new diagnosis or treatment. In older men, abnormal results were about as common with osteoporosis as without it. The yield is highest in men, premenopausal women, anyone whose bone density is far below average for their age, and anyone with a fracture that has no obvious explanation. Among people seen after a fracture, 26.5% had a newly found contributor.
Retest after you correct an abnormality, and recheck within a few months of starting a bisphosphonate if vitamin D or PTH was borderline. In one small study, four months of bisphosphonate treatment lowered average vitamin D and raised PTH by about a third. A falling trend across draws tells you more than a single result does.
Timing moves several markers at once. Vitamin D tends to fall in winter, and PTH tends to rise to match it. PTH and phosphate also rise overnight and shift after meals. A morning, fasting draw taken at the same time of year makes your results comparable from one test to the next.
A recent fracture raises ALP while the bone heals, so testing right after a break can make turnover look worse than it is. Lab artifacts happen too. Antibodies in some people's blood can interfere with the test and make PTH read falsely high, and high-dose biotin supplements can distort some hormone tests. If PTH is high but everything around it is normal, ask the lab to recheck it with a different method before you act on it.
Bone Loss Workup Panel is best interpreted alongside these tests.